Dr Brian D. Smith looks at the value of management science to real-world pharmaceutical executives.
Why don't doctors trust what pharma reps say about their products? Pierre De Nayer of Citobi tells Pharm Exec Europe that the answer is simple: the industry hasn't been telling the truth. Now it's time to change.
Neil Mahoney says it's high time pharma companies embraced competitive intelligence.
Mid-size pharma companies are best placed to succeed in the current climate. Luciano Conde, COO of Almirall, tells us why.
As costs increase and competition intensifies, Luciano Conde explains why mid-size pharma companies are better poised for success in the market.
Gary Noon talks to Pharm Exec Europe about his Big Pharma experience, his presidency of IMS (US) and his new role in bringing the pharmacist to the forefront of the industry-patient equation.
Kevin McGeehan discusses the paradigm shift in modern communication, and details how Pharm Exec Europe is staying ahead of the wave.
This issue of Pharmaceutical Executive Europe is particularly special: from January, PEE is going 'all digital'.
Pharm Exec Europe speaks to CEO Dr Nikin Patel
